“…60−63 For example, D-fagomine can effectively reduce the blood glucose peak when taken together with sucrose or starch, without stimulating insulin release and can help to eliminate the excess of enterobacteria and lower weight gain by selectively agglutinating fimbriated enterobacteria and inhibiting their adhesion to the intestinal mucosa. 64,65 Miglitol, Nhydroxyethyl DNJ, is currently used as a potent secondgeneration digestive α-glucosidase inhibitor for treatment of type II diabetes; Miglustat, N-butyl DNJ, is currently used for treatment of type 1 Gaucher disease (GD1) and Niemann− Pick type C (NPC) disease. 66−68 By simple deprotection and reductive amination, product 2, 3, and 4 were transformed to Dfagomine, DMJ and DNJ respectively with high yields, and no other diastereomers were detected by 1 H NMR analysis (Scheme 4).…”